Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-24-026858
Filing Date
2024-11-08
Accepted
2024-11-08 17:17:32
Documents
2
Period of Report
2024-11-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1364
2 POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY doc1.txt EX-24 4170
  Complete submission text file 0001127602-24-026858.txt   7250
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Issuer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O GINKGO BIOWORKS HOLDINGS, INC. 27 DRYDOCK AVENUE, 8TH FLOOR BOSTON MA 02210
Business Address
Kosuri Sri (Reporting) CIK: 0002043887 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40097 | Film No.: 241441847